Pfizer CEO Albert Bourla has admitted that his company created SARC-CoV-2 in their labs for the purposes of developing mRNA jabs rather than use a naturally-occuring coronavirus.
Bourla made the stunning admission during a CNBC interview in December 2021 while explaining how Pfizer is reformulating an mRNA vaccine to treat the Omicron variant.
“The data that we received are data that they got from what we call a pseudovirus, so it’s not the real virus, it is a virus that we have constructed in our labs and it is identical with the Omicron virus,” Bourla declared.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
Infowars.com reports: A “pseudovirus” as Bourla described is a recombinant viral particle that’s been scientifically manipulated from several different viruses to make a more pathogenic virus.
In other words, Bourla admitted Pfizer is conducting gain of function research in pursuit of creating an Omicron vaccine.
That dangerous process is exactly what EcoHealth Alliance President Peter Daszak in 2019 explained that his colleagues have been doing at the Wuhan Institute of Virology in China with bat coronaviruses.
World governments and global institutions like the World Health Organization to this day still argue that COVID-19 originated from bats at a Wuhan wet market despite overwhelming data pointing to the Wuhan Institute of Virology as the origin of COVID-19.
That’s likely because the key top U.S. scientists involved in this research, like the National Institute of Health (NIH), knew COVID-19 likely came from the Wuhan lab but worked to cover it up.
Bourla’s admission is just cover for the Wuhan lab leak of COVID-19 now that evidence is becoming incontrovertible that COVID-19 originated from the Wuhan lab as a result of dangerous gain of function research funded by EcoHealth Alliance and the NIH.